November 21st 2024
Currently, chemotherapy remains a common treatment for biliary tract cancers, which have a limited survival rate.
Flatiron's EHR Platform for OCM Participants Promises to Foster Value-Based Care
July 28th 2016To help clinics meet the objectives and reporting requirements of the Oncology Care Model (OCM), Flatiron Health has developed OncoEMR, a cloud-based electronic health record (EHR) coupled with an analytics tool.
Read More
Patient Access to Reference Pricing Prompts Choice of Lower-Cost Testing Laboratories, Cost Savings
July 27th 2016A study by researchers at the University of California, Berkeley, found that patients who have access to both the prices charged by a testing laboratory as well as reference pricing, they choose lower-cost laboratories, resulting in overall cost savings.
Read More
Breakthrough for Daratumumab for Use as Second Line With Standard of Care in Multiple Myeloma
July 26th 2016The monoclonal antibody daratumumab (Darzalex) has been granted breakthrough designation, the second for this drug, for use in combination with either lenalidomide and dexamethasone or bortezomib and dexamethasone, for patients with multiple myeloma who have received at least 1 prior therapy.
Read More